Synopsis
0
EU WC
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Neomycin
2. Neomycin Palmitate
3. Neomycin Sulfate
1. Neomycin Sulfate
2. 1405-10-3
3. Neomycin Trisulfate Hydrate
4. Akos016010116
Molecular Weight | 712.7 g/mol |
---|---|
Molecular Formula | C23H48N6O17S |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 23 |
Rotatable Bond Count | 9 |
Exact Mass | 712.27966526 g/mol |
Monoisotopic Mass | 712.27966526 g/mol |
Topological Polar Surface Area | 436 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 953 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Neomycin sulfate |
Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
Active Ingredient | Neomycin sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Oman Pharm Products; Teva; X Gen Pharms |
2 of 2 | |
---|---|
Drug Name | Neomycin sulfate |
Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
Active Ingredient | Neomycin sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Oman Pharm Products; Teva; X Gen Pharms |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13615
Submission : 1998-09-01
Status : Inactive
Type : II
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-26
Pay. Date : 2013-02-13
DMF Number : 13378
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : R1-CEP 1999-184 - Rev 03
Issue Date : 2020-04-21
Type : Chemical
Substance Number : 197
Status : Valid
Registration Number : 217MF10976
Registrant's Address : 235 East 42nd Street, New York, NY 10017
Initial Date of Registration : 2005-11-14
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32091
Submission : 2017-09-08
Status : Active
Type : II
Certificate Number : R1-CEP 2011-029 - Rev 01
Issue Date : 2020-02-27
Type : Chemical and TSE
Substance Number : 197
Status : Valid
Registration Number : 303MF10156
Registrant's Address : No. 8,Ziyang Road,Dianjun District,Yichang City,HubeiProvince,China
Initial Date of Registration : 2021-10-07
Latest Date of Registration : --
NDC Package Code : 65876-0002
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5718
Submission : 2021-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 110
Submission : 1953-05-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 264
Submission : 1957-07-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13286
Submission : 1998-09-01
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13615
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-26
Pay. Date : 2013-02-13
DMF Number : 13378
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 271
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 270
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 262
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 124
Submission : 1953-07-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13286
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 264
Submission : 1957-07-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 110
Submission : 1953-05-29
Status : Inactive
Type : II
Neomycin sulfate, Micronised and non-micronised
Certificate Number : R1-CEP 1999-184 - Rev 03
Status : Valid
Issue Date : 2020-04-21
Type : Chemical
Substance Number : 197
Certificate Number : R1-CEP 2017-006 - Rev 00
Status : Valid
Issue Date : 2023-04-13
Type : Chemical and TSE
Substance Number : 197
Certificate Number : R1-CEP 2001-317 - Rev 00
Status : Valid
Issue Date : 2010-09-07
Type : Chemical
Substance Number : 197
Certificate Number : R0-CEP 2022-013 - Rev 01
Status : Valid
Issue Date : 2023-02-15
Type : Chemical and TSE
Substance Number : 197
Certificate Number : R1-CEP 2011-029 - Rev 01
Status : Valid
Issue Date : 2020-02-27
Type : Chemical and TSE
Substance Number : 197
Registration Number : 217MF10976
Registrant's Address : 235 East 42nd Street, New York, NY 10017
Initial Date of Registration : 2005-11-14
Latest Date of Registration : 2022-06-22
Registration Number : 303MF10156
Registrant's Address : No. 8,Ziyang Road,Dianjun District,Yichang City,HubeiProvince,China
Initial Date of Registration : 2021-10-07
Latest Date of Registration : 2021-10-07
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : No
TE Code :
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
Brand Name : POLY-PRED
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.35% BASE;10,000 UNITS/ML;0.5%
Approval Date : 1982-01-01
Application Number : 50081
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : OTOCORT
Dosage Form : SOLUTION/DROPS;OTIC
Dosage Strength : 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date : 1982-01-01
Application Number : 60730
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AT
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEOMYCIN AND POLYMYXIN B SULFATE
Dosage Form : SOLUTION;IRRIGATION
Dosage Strength : EQ 40MG BASE/ML;200,000 UNITS/ML
Approval Date : 1986-04-08
Application Number : 62664
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code :
Brand Name : NEOMYCIN SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 2016-06-10
Application Number : 204435
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : AT
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : MAXITROL
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date : 1982-01-01
Application Number : 50023
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT
RLD : No
TE Code :
Brand Name : NEOBIOTIC
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 350MG BASE
Approval Date : 1982-01-01
Application Number : 60475
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
Brand Name : NEO-CORTEF
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : 1.5%;EQ 3.5MG BASE/ML
Approval Date : 1982-01-01
Application Number : 60612
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
Brand Name : NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
Dosage Form : CREAM;TOPICAL
Dosage Strength : EQ 3.5MG BASE/GM;0.1%
Approval Date : 1986-07-21
Application Number : 62595
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : NEOMYCIN SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 62173
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AT
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Dosage Form : SOLUTION/DROPS;OTIC
Dosage Strength : 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date : 1983-08-25
Application Number : 62423
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
Regulatory Info : Generic
Registration Country : Turkey
Dexamethasone; Neomycin Sulfate; Polymyxin B
Brand Name :
Dosage Form : EYE AND EAR DROPS
Dosage Strength : 1MG; 3.5MG; 6.000IU
Packaging : 5 Ml/Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : Halciderm Combi
Dosage Form :
Dosage Strength : Cream Derm 30 G 0,1 % + 0,37 %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Dexamethasone Isonicotinate; Neomycin Sulfate
Brand Name : Desalfa
Dosage Form :
Dosage Strength : Gtt Orl 10 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Hydrocortisone; Polymyxin B; Neomycin Sulfate; Lidocaine
Brand Name : Mixotone
Dosage Form :
Dosage Strength : Gtt Oto 1Vial+ 1Vial Solv 10 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NEO-TETRAMED
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 200MG/G
Packaging : 400G/2.5KG/10KG
Approval Date :
Application Number : 1976338
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NEO-CHLOR
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 20G/100G
Packaging : 100G/400G/10KG
Approval Date :
Application Number : 527335
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NEOPRO 325
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 81.25G/100G
Packaging :
Approval Date :
Application Number : 2530619
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NEO-TETRAPRO
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 200MG/G
Packaging :
Approval Date :
Application Number : 2530368
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SCOUR SUSPENSION
Dosage Form : SUSPENSION
Dosage Strength : 28.6MG/ML
Packaging : 240/250/400/500ML
Approval Date :
Application Number : 274895
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NEO-TERRAMYCIN 50/50
Dosage Form : DRUG PREMIX
Dosage Strength : 110G/Kg
Packaging : 25KG
Approval Date :
Application Number : 2325098
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ORIDERMYL
Dosage Form : OINTMENT
Dosage Strength : 3500UNIT/G
Packaging : 10G/30G
Approval Date :
Application Number : 2364166
Regulatory Info : Prescription
Registration Country : Canada
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
10 Dec 2024
Reply
22 Aug 2024
Reply
18 Jul 2024
Reply
15 Jun 2024
Reply
15 May 2024
Reply
07 Feb 2024
Reply
01 Dec 2023
Reply
03 Feb 2023
Reply
03 Feb 2023
Reply
01 Nov 2022
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?